Phase III trial of docetaxel cisplatin 5-fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome.

Wu-Tong JuYing LiuLi-Zhen WangJiang LiGuo-Xing RenJian SunWen-Yong TuYong-Jie HuTong JiWen-Jun YangJun LiYue HeYan-An WangChen-Ping ZhangLai-Ping ZhongZhi-Yuan Zhang

Published in: Cancer communications (London, England) (2021)

Keyphrases

phase iii
locally advanced
open label
rectal cancer
clinical trial
squamous cell carcinoma
phase ii
radiation therapy
double blind
placebo controlled
liver metastases
study protocol